- Home
- UCL vs SRZN Comparison
UCL vs SRZN Comparison
Compare UCL & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- SRZN
- Stock Information
- Founded
- UCL 2014
- SRZN 2015
- Country
- UCL Hong Kong
- SRZN United States
- Employees
- UCL N/A
- SRZN N/A
- Industry
- UCL Telecommunications Equipment
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- UCL Consumer Discretionary
- SRZN Health Care
- Exchange
- UCL Nasdaq
- SRZN Nasdaq
- Market Cap
- UCL 41.4M
- SRZN 38.1M
- IPO Year
- UCL 2020
- SRZN N/A
- Fundamental
- Price
- UCL $1.26
- SRZN $9.15
- Analyst Decision
- UCL
- SRZN
- Analyst Count
- UCL 0
- SRZN 0
- Target Price
- UCL N/A
- SRZN N/A
- AVG Volume (30 Days)
- UCL 13.4K
- SRZN 30.9K
- Earning Date
- UCL 11-26-2024
- SRZN 11-06-2024
- Dividend Yield
- UCL N/A
- SRZN N/A
- EPS Growth
- UCL N/A
- SRZN N/A
- EPS
- UCL 0.12
- SRZN N/A
- Revenue
- UCL $86,076,000.00
- SRZN $10,000,000.00
- Revenue This Year
- UCL $11.23
- SRZN N/A
- Revenue Next Year
- UCL $27.52
- SRZN N/A
- P/E Ratio
- UCL $10.82
- SRZN N/A
- Revenue Growth
- UCL 10.63
- SRZN N/A
- 52 Week Low
- UCL $0.97
- SRZN $6.00
- 52 Week High
- UCL $2.56
- SRZN $16.19
- Technical
- Relative Strength Index (RSI)
- UCL 57.74
- SRZN 45.09
- Support Level
- UCL $1.07
- SRZN $8.10
- Resistance Level
- UCL $1.34
- SRZN $10.76
- Average True Range (ATR)
- UCL 0.09
- SRZN 1.12
- MACD
- UCL 0.03
- SRZN -0.14
- Stochastic Oscillator
- UCL 78.35
- SRZN 25.54
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).